Status:
COMPLETED
Dose, Effects and Characteristics of Pilocarpine
Lead Sponsor:
Wills Eye
Conditions:
Open-angle Glaucoma
Eligibility:
All Genders
18-90 years
Phase:
PHASE4
Brief Summary
The purpose of this investigation, in which pilocarpine was given in repeated doses, was to evaluate: Part I - the effects of different concentrations of pilocarpine hydrochloride on intraocular press...
Detailed Description
In addition, we studied various attributes of the eye which may serve as indicators of responsiveness of individual patients to pilocarpine.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Primary open-angle glaucoma
- Primary open-angle glaucoma suspect
Exclusion
Key Trial Info
Start Date :
August 1 1978
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 1979
Estimated Enrollment :
37 Patients enrolled
Trial Details
Trial ID
NCT00803803
Start Date
August 1 1978
End Date
December 1 1979
Last Update
November 22 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wills Eye Glaucoma Service
Philadelphia, Pennsylvania, United States, 19107